{"transactions":[{"id":730195,"issuer":{"id":4569,"kind":"organization","name":"Kardigan, Inc."},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-22T23:17:42.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":57573,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option shall vest and become exercisable in thirty-six (36) equal monthly installments commencing from June 17, 2026, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":57573,"derivative":{"exercise_price":16,"expiration_date":"2036-06-16","underlying":"Common Stock","underlying_shares":57573},"source":{"system":"sec-edgar","filing":"0001193125-26-277918","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1349376/000119312526277918/ownership.xml","form_type":"4"}},{"id":730194,"issuer":{"id":4569,"kind":"organization","name":"Kardigan, Inc."},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-22T23:17:42.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":20706,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. The RSUs vest in full on June 17, 2028, subject to the Reporting Person's continuous service as of the applicable vesting date."}],"balance_after":20706,"source":{"system":"sec-edgar","filing":"0001193125-26-277918","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1349376/000119312526277918/ownership.xml","form_type":"4"}},{"id":734201,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-18T00:30:23.000Z","date":"2026-06-15","kind":"grant","planned":false,"acquired":true,"shares":1980,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and will vest on the first anniversary of the grant date, provided that it will in any case be fully vested on the date of the Issuer's 2027 annual stockholder meeting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and will vest on the first anniversary of the grant date, provided that it will in any case be fully vested on the date of the Issuer's 2027 annual stockholder meeting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and will vest on the first anniversary of the grant date, provided that it will in any case be fully vested on the date of the Issuer's 2027 annual stockholder meeting."}],"balance_after":1980,"derivative":{"underlying":"Common Stock","underlying_shares":1980},"source":{"system":"sec-edgar","filing":"0001349376-26-000004","document":"form4-06172026_080620.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000134937626000004/form4-06172026_080620.xml","form_type":"4"}},{"id":734200,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-18T00:30:23.000Z","date":"2026-06-15","kind":"grant","planned":false,"acquired":true,"shares":3772,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest on the first anniversary of the grant date, provided that the option will in any case be fully vested on the date of the Issuer's 2027 annual stockholder meeting."}],"balance_after":3772,"derivative":{"exercise_price":101,"expiration_date":"2036-06-14","underlying":"Common Stock","underlying_shares":3772},"source":{"system":"sec-edgar","filing":"0001349376-26-000004","document":"form4-06172026_080620.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000134937626000004/form4-06172026_080620.xml","form_type":"4"}},{"id":750014,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-04T22:09:04.000Z","date":"2026-06-02","kind":"grant","planned":false,"acquired":true,"shares":7490,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on June 2, 2026. Price not applicable."}],"balance_after":17270,"source":{"system":"sec-edgar","filing":"0001628280-26-040920","document":"wk-form4_1780610941.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026040920/wk-form4_1780610941.xml","form_type":"4"}},{"id":754911,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-02T23:50:12.000Z","date":"2026-05-29","kind":"exercise","planned":false,"acquired":false,"shares":3977,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests on May 29, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests on May 29, 2026."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3977},"source":{"system":"sec-edgar","filing":"0001349376-26-000002","document":"form4-06022026_070607.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000134937626000002/form4-06022026_070607.xml","form_type":"4"}},{"id":754910,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-02T23:50:12.000Z","date":"2026-05-29","kind":"exercise","planned":false,"acquired":true,"shares":3977,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer)."}],"balance_after":9680,"source":{"system":"sec-edgar","filing":"0001349376-26-000002","document":"form4-06022026_070607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000134937626000002/form4-06022026_070607.xml","form_type":"4"}},{"id":784450,"issuer":{"id":4850,"kind":"organization","name":"Odyssey Therapeutics, Inc."},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-12T00:30:08.000Z","date":"2026-05-07","kind":"grant","planned":false,"acquired":true,"shares":27393,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option will vest in full on May 7, 2027, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":27393,"derivative":{"exercise_price":18,"expiration_date":"2036-05-06","underlying":"Common Stock","underlying_shares":27393},"source":{"system":"sec-edgar","filing":"0001193125-26-217586","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1349376/000119312526217586/ownership.xml","form_type":"4"}},{"id":1109901,"issuer":{"id":5739,"kind":"organization","name":"Century Therapeutics, Inc.","symbol":"IPSC"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-16T22:23:22.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":44000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on the earlier of (a) June 12, 2026, or (b) the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":44000,"derivative":{"exercise_price":0.6,"expiration_date":"2035-06-12","underlying":"Common Stock","underlying_shares":44000},"source":{"system":"sec-edgar","filing":"0001062993-25-011782","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850119/000106299325011782/form4.xml","form_type":"4"}},{"id":1116069,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-10T21:43:22.000Z","date":"2025-06-09","kind":"grant","planned":false,"acquired":true,"shares":32250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest and become exercisable over twelve (12) equal monthly installments following June 9, 2025, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":32250,"derivative":{"exercise_price":5.33,"expiration_date":"2035-06-08","underlying":"Series A Common Stock","underlying_shares":32250},"source":{"system":"sec-edgar","filing":"0001104659-25-058226","document":"tm2517621-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1349376/000110465925058226/tm2517621-7_4seq1.xml","form_type":"4"}},{"id":1127741,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-02T23:30:41.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":3977,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and will vest on the first anniversary of the grant date, provided that it will in any case be fully vested on the date of the Issuer's 2026 annual stockholder meeting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and will vest on the first anniversary of the grant date, provided that it will in any case be fully vested on the date of the Issuer's 2026 annual stockholder meeting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and will vest on the first anniversary of the grant date, provided that it will in any case be fully vested on the date of the Issuer's 2026 annual stockholder meeting."}],"balance_after":3977,"derivative":{"underlying":"Common Stock","underlying_shares":3977},"source":{"system":"sec-edgar","filing":"0001415889-25-015299","document":"form4-06022025_110638.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588925015299/form4-06022025_110638.xml","form_type":"4"}},{"id":1127740,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-02T23:30:41.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":6268,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares vest on the first anniversary of the grant date, provided that the option will in any case be fully vested on the date of the Issuer's 2026 annual stockholder meeting."}],"balance_after":6268,"derivative":{"exercise_price":44,"expiration_date":"2035-05-28","underlying":"Common Stock","underlying_shares":6268},"source":{"system":"sec-edgar","filing":"0001415889-25-015299","document":"form4-06022025_110638.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588925015299/form4-06022025_110638.xml","form_type":"4"}},{"id":1127739,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-02T23:30:41.000Z","date":"2025-05-29","kind":"exercise","planned":false,"acquired":false,"shares":5703,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock unit vests on the first anniversary of the grant date, provided  that it will in any case be fully vested on the date of the Issuer's 2025 annual stockholder meeting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock unit vests on the first anniversary of the grant date, provided  that it will in any case be fully vested on the date of the Issuer's 2025 annual stockholder meeting."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5703},"source":{"system":"sec-edgar","filing":"0001415889-25-015299","document":"form4-06022025_110638.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588925015299/form4-06022025_110638.xml","form_type":"4"}},{"id":1127738,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-02T23:30:41.000Z","date":"2025-05-29","kind":"exercise","planned":false,"acquired":true,"shares":5703,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer)."}],"balance_after":5703,"source":{"system":"sec-edgar","filing":"0001415889-25-015299","document":"form4-06022025_110638.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588925015299/form4-06022025_110638.xml","form_type":"4"}},{"id":1137826,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-22T21:01:26.000Z","date":"2025-05-20","kind":"grant","planned":false,"acquired":true,"shares":6650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on May 20, 2025. Price not applicable."}],"balance_after":9780,"source":{"system":"sec-edgar","filing":"0001048477-25-000078","document":"wk-form4_1747947678.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000078/wk-form4_1747947678.xml","form_type":"4"}},{"id":1243890,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-26T21:18:50.000Z","date":"2025-02-24","kind":"grant","planned":false,"acquired":true,"shares":3130,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on February 24, 2025. Price not applicable."}],"balance_after":3130,"source":{"system":"sec-edgar","filing":"0001048477-25-000013","document":"wk-form4_1740604721.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000013/wk-form4_1740604721.xml","form_type":"4"}},{"id":1472181,"issuer":{"id":5739,"kind":"organization","name":"Century Therapeutics, Inc.","symbol":"IPSC"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-21T20:51:03.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":44000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on the earlier of (a) June 20, 2025, or (b) the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":44000,"derivative":{"exercise_price":2.69,"expiration_date":"2034-06-20","underlying":"Common Stock","underlying_shares":44000},"source":{"system":"sec-edgar","filing":"0001062993-24-012906","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850119/000106299324012906/form4.xml","form_type":"4"}},{"id":1486950,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-06-07T22:24:35.000Z","date":"2024-06-05","kind":"grant","planned":true,"acquired":true,"shares":5703,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and will vest on the first anniversary of the grant date, provided that it will in any case be fully vested on the date of the Issuer's 2025 annual stockholder meeting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and will vest on the first anniversary of the grant date, provided that it will in any case be fully vested on the date of the Issuer's 2025 annual stockholder meeting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and will vest on the first anniversary of the grant date, provided that it will in any case be fully vested on the date of the Issuer's 2025 annual stockholder meeting."}],"balance_after":5703,"derivative":{"underlying":"Common Stock","underlying_shares":5703},"source":{"system":"sec-edgar","filing":"0001415889-24-016070","document":"form4-06072024_100631.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588924016070/form4-06072024_100631.xml","form_type":"4"}},{"id":1486949,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-07T22:24:35.000Z","date":"2024-06-05","kind":"grant","planned":true,"acquired":true,"shares":8779,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest on the first anniversary of the grant date, provided that the option will in any case be fully vested on the date of the Company's 2025 annual stockholder meeting."}],"balance_after":8779,"derivative":{"exercise_price":26.3,"expiration_date":"2034-06-04","underlying":"Common Stock","underlying_shares":8779},"source":{"system":"sec-edgar","filing":"0001415889-24-016070","document":"form4-06072024_100631.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588924016070/form4-06072024_100631.xml","form_type":"4"}},{"id":1486322,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-07T20:08:05.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":9279,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest and become exercisable over twelve (12) equal monthly installments following June 5, 2024, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":9279,"derivative":{"exercise_price":4.64,"expiration_date":"2034-06-04","underlying":"Series A Common Stock","underlying_shares":9279},"source":{"system":"sec-edgar","filing":"0001104659-24-069639","document":"tm2416701-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1349376/000110465924069639/tm2416701-5_4seq1.xml","form_type":"4"}},{"id":1548930,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-04-04T00:19:01.000Z","date":"2024-04-01","kind":"grant","planned":false,"acquired":true,"shares":73014,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest and become exercisable over thirty-six (36) equal monthly installments following April 1, 2024, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":73014,"derivative":{"exercise_price":5.23,"expiration_date":"2034-03-31","underlying":"Series A Common Stock","underlying_shares":73014},"source":{"system":"sec-edgar","filing":"0001104659-24-043264","document":"tm2410971-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1349376/000110465924043264/tm2410971-4_4seq1.xml","form_type":"4"}},{"id":1763519,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Performance Restricted Stock Units","published_at":"2023-10-06T17:57:24.000Z","date":"2023-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5174,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each RSU (as defined in footnote 9 to this Form 4) and PSU (as defined in footnote 13 to this Form 4) represents a contingent right to receive one Ordinary Share of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"Reflects the disposition of Issuer's restricted stock unit awards with performance-based vesting or delivery requirements (each, a \"PSU\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding PSU (whether or not vested) was canceled and converted into the right to receive cash, without interest, in an amount equal to (i) the total number of Ordinary Shares issuable in settlement of such PSU (as determined in accordance with the Transaction Agreement) multiplied by (ii) the Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F17","text":"The Ordinary Shares subject to the PSUs vest 2/3rd on January 5, 2025 and the remaining shares vest on January 5, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F17","text":"The Ordinary Shares subject to the PSUs vest 2/3rd on January 5, 2025 and the remaining shares vest on January 5, 2026."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":5174},"source":{"system":"sec-edgar","filing":"0001209191-23-052361","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":27,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123052361/doc4.xml","form_type":"4"}},{"id":1763518,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Performance Restricted Stock Units","published_at":"2023-10-06T17:57:24.000Z","date":"2023-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5174,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F13","text":"Reflects the disposition of Issuer's restricted stock unit awards with performance-based vesting or delivery requirements (each, a \"PSU\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding PSU (whether or not vested) was canceled and converted into the right to receive cash, without interest, in an amount equal to (i) the total number of Ordinary Shares issuable in settlement of such PSU (as determined in accordance with the Transaction Agreement) multiplied by (ii) the Consideration."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"Reflects the disposition of Issuer's restricted stock unit awards with performance-based vesting or delivery requirements (each, a \"PSU\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding PSU (whether or not vested) was canceled and converted into the right to receive cash, without interest, in an amount equal to (i) the total number of Ordinary Shares issuable in settlement of such PSU (as determined in accordance with the Transaction Agreement) multiplied by (ii) the Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F17","text":"The Ordinary Shares subject to the PSUs vest 2/3rd on January 5, 2025 and the remaining shares vest on January 5, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F17","text":"The Ordinary Shares subject to the PSUs vest 2/3rd on January 5, 2025 and the remaining shares vest on January 5, 2026."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":5174},"source":{"system":"sec-edgar","filing":"0001209191-23-052361","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":26,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123052361/doc4.xml","form_type":"4"}},{"id":1763517,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Performance Restricted Stock Units","published_at":"2023-10-06T17:57:24.000Z","date":"2023-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":10349,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each RSU (as defined in footnote 9 to this Form 4) and PSU (as defined in footnote 13 to this Form 4) represents a contingent right to receive one Ordinary Share of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"Reflects the disposition of Issuer's restricted stock unit awards with performance-based vesting or delivery requirements (each, a \"PSU\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding PSU (whether or not vested) was canceled and converted into the right to receive cash, without interest, in an amount equal to (i) the total number of Ordinary Shares issuable in settlement of such PSU (as determined in accordance with the Transaction Agreement) multiplied by (ii) the Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F16","text":"The Ordinary Shares subject to the PSUs vest on January 5, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F16","text":"The Ordinary Shares subject to the PSUs vest on January 5, 2026."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":10349},"source":{"system":"sec-edgar","filing":"0001209191-23-052361","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":25,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123052361/doc4.xml","form_type":"4"}},{"id":1763516,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Performance Restricted Stock Units","published_at":"2023-10-06T17:57:24.000Z","date":"2023-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":4285,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each RSU (as defined in footnote 9 to this Form 4) and PSU (as defined in footnote 13 to this Form 4) represents a contingent right to receive one Ordinary Share of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"Reflects the disposition of Issuer's restricted stock unit awards with performance-based vesting or delivery requirements (each, a \"PSU\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding PSU (whether or not vested) was canceled and converted into the right to receive cash, without interest, in an amount equal to (i) the total number of Ordinary Shares issuable in settlement of such PSU (as determined in accordance with the Transaction Agreement) multiplied by (ii) the Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F14","text":"The Ordinary Shares subject to the PSUs vest 2/3rd on January 5, 2024 and the remaining shares vest on January 5, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F14","text":"The Ordinary Shares subject to the PSUs vest 2/3rd on January 5, 2024 and the remaining shares vest on January 5, 2025."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":4285},"source":{"system":"sec-edgar","filing":"0001209191-23-052361","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123052361/doc4.xml","form_type":"4"}},{"id":1763515,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Performance Restricted Stock Units","published_at":"2023-10-06T17:57:24.000Z","date":"2023-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":12854,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each RSU (as defined in footnote 9 to this Form 4) and PSU (as defined in footnote 13 to this Form 4) represents a contingent right to receive one Ordinary Share of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"Reflects the disposition of Issuer's restricted stock unit awards with performance-based vesting or delivery requirements (each, a \"PSU\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding PSU (whether or not vested) was canceled and converted into the right to receive cash, without interest, in an amount equal to (i) the total number of Ordinary Shares issuable in settlement of such PSU (as determined in accordance with the Transaction Agreement) multiplied by (ii) the Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F15","text":"The Ordinary Shares subject to the PSUs vest on January 5, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F15","text":"The Ordinary Shares subject to the PSUs vest on January 5, 2025."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":12854},"source":{"system":"sec-edgar","filing":"0001209191-23-052361","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123052361/doc4.xml","form_type":"4"}},{"id":1763514,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Performance Restricted Stock Units","published_at":"2023-10-06T17:57:24.000Z","date":"2023-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":21426,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each RSU (as defined in footnote 9 to this Form 4) and PSU (as defined in footnote 13 to this Form 4) represents a contingent right to receive one Ordinary Share of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"Reflects the disposition of Issuer's restricted stock unit awards with performance-based vesting or delivery requirements (each, a \"PSU\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding PSU (whether or not vested) was canceled and converted into the right to receive cash, without interest, in an amount equal to (i) the total number of Ordinary Shares issuable in settlement of such PSU (as determined in accordance with the Transaction Agreement) multiplied by (ii) the Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F15","text":"The Ordinary Shares subject to the PSUs vest on January 5, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F15","text":"The Ordinary Shares subject to the PSUs vest on January 5, 2025."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":21426},"source":{"system":"sec-edgar","filing":"0001209191-23-052361","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123052361/doc4.xml","form_type":"4"}},{"id":1763513,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Restricted Stock Units","published_at":"2023-10-06T17:57:24.000Z","date":"2023-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":20697,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each RSU (as defined in footnote 9 to this Form 4) and PSU (as defined in footnote 13 to this Form 4) represents a contingent right to receive one Ordinary Share of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Reflects the disposition of Issuer's restricted stock unit awards, excluding PSUs (as defined in footnote 14 to this Form 4), (each, a \"RSU\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding RSU (whether or not vested) was assumed and converted into a restricted stock unit (each, a \"Parent RSU\") denominated in shares of Parent's common stock. The number of shares of Parent's common stock subject to each such Parent RSU was equal to the product (rounded down to the nearest whole number) of (y) the number of shares of Ordinary Shares subject to the RSU immediately prior to the Effective Time multiplied by (z) the ratio equal to (1) the Consideration divided by (2) the volume weighted average of the per share closing price of Parent's common stock on the Nasdaq for five (5) trading days ending on the second business day prior to the completion of the Scheme."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"The Ordinary Shares subject to the RSUs vest 1/3rd annually on each anniversary of January 5, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F11","text":"The Ordinary Shares subject to the RSUs vest 1/3rd annually on each anniversary of January 5, 2023."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":20697},"source":{"system":"sec-edgar","filing":"0001209191-23-052361","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123052361/doc4.xml","form_type":"4"}},{"id":1763512,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Restricted Stock Units","published_at":"2023-10-06T17:57:24.000Z","date":"2023-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":14283,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each RSU (as defined in footnote 9 to this Form 4) and PSU (as defined in footnote 13 to this Form 4) represents a contingent right to receive one Ordinary Share of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Reflects the disposition of Issuer's restricted stock unit awards, excluding PSUs (as defined in footnote 14 to this Form 4), (each, a \"RSU\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding RSU (whether or not vested) was assumed and converted into a restricted stock unit (each, a \"Parent RSU\") denominated in shares of Parent's common stock. The number of shares of Parent's common stock subject to each such Parent RSU was equal to the product (rounded down to the nearest whole number) of (y) the number of shares of Ordinary Shares subject to the RSU immediately prior to the Effective Time multiplied by (z) the ratio equal to (1) the Consideration divided by (2) the volume weighted average of the per share closing price of Parent's common stock on the Nasdaq for five (5) trading days ending on the second business day prior to the completion of the Scheme."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The Ordinary Shares subject to the RSUs vest 1/3rd annually on each anniversary of January 5, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"The Ordinary Shares subject to the RSUs vest 1/3rd annually on each anniversary of January 5, 2022."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":14283},"source":{"system":"sec-edgar","filing":"0001209191-23-052361","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123052361/doc4.xml","form_type":"4"}},{"id":1763511,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Restricted Stock Units","published_at":"2023-10-06T17:57:24.000Z","date":"2023-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":4657,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each RSU (as defined in footnote 9 to this Form 4) and PSU (as defined in footnote 13 to this Form 4) represents a contingent right to receive one Ordinary Share of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Reflects the disposition of Issuer's restricted stock unit awards, excluding PSUs (as defined in footnote 14 to this Form 4), (each, a \"RSU\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding RSU (whether or not vested) was assumed and converted into a restricted stock unit (each, a \"Parent RSU\") denominated in shares of Parent's common stock. The number of shares of Parent's common stock subject to each such Parent RSU was equal to the product (rounded down to the nearest whole number) of (y) the number of shares of Ordinary Shares subject to the RSU immediately prior to the Effective Time multiplied by (z) the ratio equal to (1) the Consideration divided by (2) the volume weighted average of the per share closing price of Parent's common stock on the Nasdaq for five (5) trading days ending on the second business day prior to the completion of the Scheme."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"The Ordinary Shares subject to the PSUs (as defined in footnote 13 to this Form 4) vest on January 5, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F12","text":"The Ordinary Shares subject to the PSUs (as defined in footnote 13 to this Form 4) vest on January 5, 2024."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":4657},"source":{"system":"sec-edgar","filing":"0001209191-23-052361","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123052361/doc4.xml","form_type":"4"}},{"id":1763510,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Performance Restricted Stock Units","published_at":"2023-10-06T17:57:24.000Z","date":"2023-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":17823,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each RSU (as defined in footnote 9 to this Form 4) and PSU (as defined in footnote 13 to this Form 4) represents a contingent right to receive one Ordinary Share of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"Reflects the disposition of Issuer's restricted stock unit awards with performance-based vesting or delivery requirements (each, a \"PSU\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding PSU (whether or not vested) was canceled and converted into the right to receive cash, without interest, in an amount equal to (i) the total number of Ordinary Shares issuable in settlement of such PSU (as determined in accordance with the Transaction Agreement) multiplied by (ii) the Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F17","text":"The Ordinary Shares subject to the PSUs vest 2/3rd on January 5, 2025 and the remaining shares vest on January 5, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F17","text":"The Ordinary Shares subject to the PSUs vest 2/3rd on January 5, 2025 and the remaining shares vest on January 5, 2026."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":17823},"source":{"system":"sec-edgar","filing":"0001209191-23-052361","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123052361/doc4.xml","form_type":"4"}},{"id":1763509,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Performance Restricted Stock Units","published_at":"2023-10-06T17:57:24.000Z","date":"2023-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":17823,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each RSU (as defined in footnote 9 to this Form 4) and PSU (as defined in footnote 13 to this Form 4) represents a contingent right to receive one Ordinary Share of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"Reflects the disposition of Issuer's restricted stock unit awards with performance-based vesting or delivery requirements (each, a \"PSU\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding PSU (whether or not vested) was canceled and converted into the right to receive cash, without interest, in an amount equal to (i) the total number of Ordinary Shares issuable in settlement of such PSU (as determined in accordance with the Transaction Agreement) multiplied by (ii) the Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F17","text":"The Ordinary Shares subject to the PSUs vest 2/3rd on January 5, 2025 and the remaining shares vest on January 5, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F17","text":"The Ordinary Shares subject to the PSUs vest 2/3rd on January 5, 2025 and the remaining shares vest on January 5, 2026."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":17823},"source":{"system":"sec-edgar","filing":"0001209191-23-052361","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123052361/doc4.xml","form_type":"4"}},{"id":1763508,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Performance Restricted Stock Units","published_at":"2023-10-06T17:57:24.000Z","date":"2023-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":35645,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each RSU (as defined in footnote 9 to this Form 4) and PSU (as defined in footnote 13 to this Form 4) represents a contingent right to receive one Ordinary Share of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"Reflects the disposition of Issuer's restricted stock unit awards with performance-based vesting or delivery requirements (each, a \"PSU\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding PSU (whether or not vested) was canceled and converted into the right to receive cash, without interest, in an amount equal to (i) the total number of Ordinary Shares issuable in settlement of such PSU (as determined in accordance with the Transaction Agreement) multiplied by (ii) the Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F16","text":"The Ordinary Shares subject to the PSUs vest on January 5, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F16","text":"The Ordinary Shares subject to the PSUs vest on January 5, 2026."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":35645},"source":{"system":"sec-edgar","filing":"0001209191-23-052361","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123052361/doc4.xml","form_type":"4"}},{"id":1763507,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Performance Restricted Stock Units","published_at":"2023-10-06T17:57:24.000Z","date":"2023-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":73798,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each RSU (as defined in footnote 9 to this Form 4) and PSU (as defined in footnote 13 to this Form 4) represents a contingent right to receive one Ordinary Share of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"Reflects the disposition of Issuer's restricted stock unit awards with performance-based vesting or delivery requirements (each, a \"PSU\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding PSU (whether or not vested) was canceled and converted into the right to receive cash, without interest, in an amount equal to (i) the total number of Ordinary Shares issuable in settlement of such PSU (as determined in accordance with the Transaction Agreement) multiplied by (ii) the Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F15","text":"The Ordinary Shares subject to the PSUs vest on January 5, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F15","text":"The Ordinary Shares subject to the PSUs vest on January 5, 2025."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":73798},"source":{"system":"sec-edgar","filing":"0001209191-23-052361","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123052361/doc4.xml","form_type":"4"}},{"id":1763506,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Performance Restricted Stock Units","published_at":"2023-10-06T17:57:24.000Z","date":"2023-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":44278,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each RSU (as defined in footnote 9 to this Form 4) and PSU (as defined in footnote 13 to this Form 4) represents a contingent right to receive one Ordinary Share of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"Reflects the disposition of Issuer's restricted stock unit awards with performance-based vesting or delivery requirements (each, a \"PSU\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding PSU (whether or not vested) was canceled and converted into the right to receive cash, without interest, in an amount equal to (i) the total number of Ordinary Shares issuable in settlement of such PSU (as determined in accordance with the Transaction Agreement) multiplied by (ii) the Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F15","text":"The Ordinary Shares subject to the PSUs vest on January 5, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F15","text":"The Ordinary Shares subject to the PSUs vest on January 5, 2025."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":44278},"source":{"system":"sec-edgar","filing":"0001209191-23-052361","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123052361/doc4.xml","form_type":"4"}},{"id":1763505,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Performance Restricted Stock Units","published_at":"2023-10-06T17:57:24.000Z","date":"2023-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":14759,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each RSU (as defined in footnote 9 to this Form 4) and PSU (as defined in footnote 13 to this Form 4) represents a contingent right to receive one Ordinary Share of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"Reflects the disposition of Issuer's restricted stock unit awards with performance-based vesting or delivery requirements (each, a \"PSU\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding PSU (whether or not vested) was canceled and converted into the right to receive cash, without interest, in an amount equal to (i) the total number of Ordinary Shares issuable in settlement of such PSU (as determined in accordance with the Transaction Agreement) multiplied by (ii) the Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F14","text":"The Ordinary Shares subject to the PSUs vest 2/3rd on January 5, 2024 and the remaining shares vest on January 5, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F14","text":"The Ordinary Shares subject to the PSUs vest 2/3rd on January 5, 2024 and the remaining shares vest on January 5, 2025."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":14759},"source":{"system":"sec-edgar","filing":"0001209191-23-052361","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123052361/doc4.xml","form_type":"4"}},{"id":1763504,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Performance Restricted Stock Units","published_at":"2023-10-06T17:57:24.000Z","date":"2023-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":104786,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each RSU (as defined in footnote 9 to this Form 4) and PSU (as defined in footnote 13 to this Form 4) represents a contingent right to receive one Ordinary Share of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"Reflects the disposition of Issuer's restricted stock unit awards with performance-based vesting or delivery requirements (each, a \"PSU\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding PSU (whether or not vested) was canceled and converted into the right to receive cash, without interest, in an amount equal to (i) the total number of Ordinary Shares issuable in settlement of such PSU (as determined in accordance with the Transaction Agreement) multiplied by (ii) the Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"The Ordinary Shares subject to the PSUs (as defined in footnote 13 to this Form 4) vest on January 5, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F12","text":"The Ordinary Shares subject to the PSUs (as defined in footnote 13 to this Form 4) vest on January 5, 2024."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":104786},"source":{"system":"sec-edgar","filing":"0001209191-23-052361","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123052361/doc4.xml","form_type":"4"}},{"id":1763503,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Performance Restricted Stock Units","published_at":"2023-10-06T17:57:24.000Z","date":"2023-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":17448,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each RSU (as defined in footnote 9 to this Form 4) and PSU (as defined in footnote 13 to this Form 4) represents a contingent right to receive one Ordinary Share of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"Reflects the disposition of Issuer's restricted stock unit awards with performance-based vesting or delivery requirements (each, a \"PSU\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding PSU (whether or not vested) was canceled and converted into the right to receive cash, without interest, in an amount equal to (i) the total number of Ordinary Shares issuable in settlement of such PSU (as determined in accordance with the Transaction Agreement) multiplied by (ii) the Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"The Ordinary Shares subject to the PSUs (as defined in footnote 13 to this Form 4) vest on January 5, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F12","text":"The Ordinary Shares subject to the PSUs (as defined in footnote 13 to this Form 4) vest on January 5, 2024."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":17448},"source":{"system":"sec-edgar","filing":"0001209191-23-052361","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123052361/doc4.xml","form_type":"4"}},{"id":1763502,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Performance Restricted Stock Units","published_at":"2023-10-06T17:57:24.000Z","date":"2023-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":45843,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each RSU (as defined in footnote 9 to this Form 4) and PSU (as defined in footnote 13 to this Form 4) represents a contingent right to receive one Ordinary Share of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"Reflects the disposition of Issuer's restricted stock unit awards with performance-based vesting or delivery requirements (each, a \"PSU\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding PSU (whether or not vested) was canceled and converted into the right to receive cash, without interest, in an amount equal to (i) the total number of Ordinary Shares issuable in settlement of such PSU (as determined in accordance with the Transaction Agreement) multiplied by (ii) the Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"The Ordinary Shares subject to the PSUs (as defined in footnote 13 to this Form 4) vest on January 5, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F12","text":"The Ordinary Shares subject to the PSUs (as defined in footnote 13 to this Form 4) vest on January 5, 2024."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":45843},"source":{"system":"sec-edgar","filing":"0001209191-23-052361","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123052361/doc4.xml","form_type":"4"}},{"id":1763501,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Restricted Stock Units","published_at":"2023-10-06T17:57:24.000Z","date":"2023-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":71290,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each RSU (as defined in footnote 9 to this Form 4) and PSU (as defined in footnote 13 to this Form 4) represents a contingent right to receive one Ordinary Share of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Reflects the disposition of Issuer's restricted stock unit awards, excluding PSUs (as defined in footnote 14 to this Form 4), (each, a \"RSU\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding RSU (whether or not vested) was assumed and converted into a restricted stock unit (each, a \"Parent RSU\") denominated in shares of Parent's common stock. The number of shares of Parent's common stock subject to each such Parent RSU was equal to the product (rounded down to the nearest whole number) of (y) the number of shares of Ordinary Shares subject to the RSU immediately prior to the Effective Time multiplied by (z) the ratio equal to (1) the Consideration divided by (2) the volume weighted average of the per share closing price of Parent's common stock on the Nasdaq for five (5) trading days ending on the second business day prior to the completion of the Scheme."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"The Ordinary Shares subject to the RSUs vest 1/3rd annually on each anniversary of January 5, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F11","text":"The Ordinary Shares subject to the RSUs vest 1/3rd annually on each anniversary of January 5, 2023."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":71290},"source":{"system":"sec-edgar","filing":"0001209191-23-052361","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123052361/doc4.xml","form_type":"4"}},{"id":1763500,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Restricted Stock Units","published_at":"2023-10-06T17:57:24.000Z","date":"2023-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":49198,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each RSU (as defined in footnote 9 to this Form 4) and PSU (as defined in footnote 13 to this Form 4) represents a contingent right to receive one Ordinary Share of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Reflects the disposition of Issuer's restricted stock unit awards, excluding PSUs (as defined in footnote 14 to this Form 4), (each, a \"RSU\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding RSU (whether or not vested) was assumed and converted into a restricted stock unit (each, a \"Parent RSU\") denominated in shares of Parent's common stock. The number of shares of Parent's common stock subject to each such Parent RSU was equal to the product (rounded down to the nearest whole number) of (y) the number of shares of Ordinary Shares subject to the RSU immediately prior to the Effective Time multiplied by (z) the ratio equal to (1) the Consideration divided by (2) the volume weighted average of the per share closing price of Parent's common stock on the Nasdaq for five (5) trading days ending on the second business day prior to the completion of the Scheme."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The Ordinary Shares subject to the RSUs vest 1/3rd annually on each anniversary of January 5, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"The Ordinary Shares subject to the RSUs vest 1/3rd annually on each anniversary of January 5, 2022."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":49198},"source":{"system":"sec-edgar","filing":"0001209191-23-052361","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123052361/doc4.xml","form_type":"4"}},{"id":1763499,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Restricted Stock Units","published_at":"2023-10-06T17:57:24.000Z","date":"2023-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":34929,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each RSU (as defined in footnote 9 to this Form 4) and PSU (as defined in footnote 13 to this Form 4) represents a contingent right to receive one Ordinary Share of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Reflects the disposition of Issuer's restricted stock unit awards, excluding PSUs (as defined in footnote 14 to this Form 4), (each, a \"RSU\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding RSU (whether or not vested) was assumed and converted into a restricted stock unit (each, a \"Parent RSU\") denominated in shares of Parent's common stock. The number of shares of Parent's common stock subject to each such Parent RSU was equal to the product (rounded down to the nearest whole number) of (y) the number of shares of Ordinary Shares subject to the RSU immediately prior to the Effective Time multiplied by (z) the ratio equal to (1) the Consideration divided by (2) the volume weighted average of the per share closing price of Parent's common stock on the Nasdaq for five (5) trading days ending on the second business day prior to the completion of the Scheme."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The Ordinary Shares subject to the RSUs vest on January 5, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"The Ordinary Shares subject to the RSUs vest on January 5, 2024."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":34929},"source":{"system":"sec-edgar","filing":"0001209191-23-052361","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123052361/doc4.xml","form_type":"4"}},{"id":1763498,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-10-06T17:57:24.000Z","date":"2023-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1650000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Reflects the disposition of Issuer's options to purchase Ordinary Shares (each, an \"Option\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding Option (whether or not vested) was canceled and converted into the right to receive cash, without interest, in an amount equal to (a) the total number of Ordinary Shares subject to such Option, multiplied by (b) the excess of (i) the Consideration over (ii) the exercise price payable per Ordinary Share under such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Option (as defined in footnote 6 to this Form 4) is fully vested."}],"balance_after":0,"derivative":{"exercise_price":28.53,"expiration_date":"2025-03-22","underlying":"Ordinary Shares","underlying_shares":1650000},"source":{"system":"sec-edgar","filing":"0001209191-23-052361","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123052361/doc4.xml","form_type":"4"}},{"id":1763497,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-10-06T17:57:24.000Z","date":"2023-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":742565,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Reflects the disposition of Issuer's options to purchase Ordinary Shares (each, an \"Option\") as contemplated by the Transaction Agreement. Pursuant to the Transaction Agreement, at the Effective Time, each outstanding Option (whether or not vested) was canceled and converted into the right to receive cash, without interest, in an amount equal to (a) the total number of Ordinary Shares subject to such Option, multiplied by (b) the excess of (i) the Consideration over (ii) the exercise price payable per Ordinary Share under such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Option (as defined in footnote 6 to this Form 4) is fully vested."}],"balance_after":0,"derivative":{"exercise_price":22.14,"expiration_date":"2025-03-22","underlying":"Ordinary Shares","underlying_shares":742565},"source":{"system":"sec-edgar","filing":"0001209191-23-052361","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123052361/doc4.xml","form_type":"4"}},{"id":1763496,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Ordinary Shares","published_at":"2023-10-06T17:57:24.000Z","date":"2023-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":49935,"price":116.5,"value":5817427.5,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Includes 279 Ordinary Shares (as defined in footnote 2 of this Form 4) acquired by the reporting person on June 1, 2023 pursuant to an employee stock purchase program."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the disposition of ordinary shares of Horizon Therapeutics plc (\"Issuer\"), nominal value $0.0001 per share (\"Ordinary Shares\"), in connection with the consummation of the transactions contemplated by the Transaction Agreement (the \"Transaction Agreement\"), dated as of December 11, 2022, by and among Issuer, Amgen Inc. (\"Parent\"), and Pillartree Limited, a wholly owned subsidiary of Parent (\"Acquirer Sub\"), including the consummation of a scheme of arrangement under Chapter 1 of Part 9 of the Companies Act 2014 of Ireland (the \"Scheme\") pursuant to which Acquirer Sub acquired Issuer. Pursuant to the Transaction Agreement, on October 6, 2023, the effective time of the Scheme (the \"Effective Time\"), each outstanding Ordinary Share was converted into $116.50 in cash (the \"Consideration\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-052361","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123052361/doc4.xml","form_type":"4"}},{"id":1763495,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Ordinary Shares","published_at":"2023-10-06T17:57:24.000Z","date":"2023-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":100300,"price":116.5,"value":11684950.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the disposition of ordinary shares of Horizon Therapeutics plc (\"Issuer\"), nominal value $0.0001 per share (\"Ordinary Shares\"), in connection with the consummation of the transactions contemplated by the Transaction Agreement (the \"Transaction Agreement\"), dated as of December 11, 2022, by and among Issuer, Amgen Inc. (\"Parent\"), and Pillartree Limited, a wholly owned subsidiary of Parent (\"Acquirer Sub\"), including the consummation of a scheme of arrangement under Chapter 1 of Part 9 of the Companies Act 2014 of Ireland (the \"Scheme\") pursuant to which Acquirer Sub acquired Issuer. Pursuant to the Transaction Agreement, on October 6, 2023, the effective time of the Scheme (the \"Effective Time\"), each outstanding Ordinary Share was converted into $116.50 in cash (the \"Consideration\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The Ordinary Shares are held by the Keli B. Walbert 2021 Gift Trust, of which the Reporting Person is the Trustee. The beneficiaries of the Trust include the Reporting Person and his descendants."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-052361","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123052361/doc4.xml","form_type":"4"}},{"id":1763494,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Ordinary Shares","published_at":"2023-10-06T17:57:24.000Z","date":"2023-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":107739,"price":116.5,"value":12551593.5,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the disposition of ordinary shares of Horizon Therapeutics plc (\"Issuer\"), nominal value $0.0001 per share (\"Ordinary Shares\"), in connection with the consummation of the transactions contemplated by the Transaction Agreement (the \"Transaction Agreement\"), dated as of December 11, 2022, by and among Issuer, Amgen Inc. (\"Parent\"), and Pillartree Limited, a wholly owned subsidiary of Parent (\"Acquirer Sub\"), including the consummation of a scheme of arrangement under Chapter 1 of Part 9 of the Companies Act 2014 of Ireland (the \"Scheme\") pursuant to which Acquirer Sub acquired Issuer. Pursuant to the Transaction Agreement, on October 6, 2023, the effective time of the Scheme (the \"Effective Time\"), each outstanding Ordinary Share was converted into $116.50 in cash (the \"Consideration\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Ordinary Shares are held by the Timothy P. Walbert 2021 Gift Trust, of which the Reporting Person's spouse is the Trustee and beneficiary."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-052361","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123052361/doc4.xml","form_type":"4"}},{"id":1763493,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Ordinary Shares","published_at":"2023-10-06T17:57:24.000Z","date":"2023-10-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":616772,"price":116.5,"value":71853938.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Includes 279 Ordinary Shares (as defined in footnote 2 of this Form 4) acquired by the reporting person on June 1, 2023 pursuant to an employee stock purchase program."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the disposition of ordinary shares of Horizon Therapeutics plc (\"Issuer\"), nominal value $0.0001 per share (\"Ordinary Shares\"), in connection with the consummation of the transactions contemplated by the Transaction Agreement (the \"Transaction Agreement\"), dated as of December 11, 2022, by and among Issuer, Amgen Inc. (\"Parent\"), and Pillartree Limited, a wholly owned subsidiary of Parent (\"Acquirer Sub\"), including the consummation of a scheme of arrangement under Chapter 1 of Part 9 of the Companies Act 2014 of Ireland (the \"Scheme\") pursuant to which Acquirer Sub acquired Issuer. Pursuant to the Transaction Agreement, on October 6, 2023, the effective time of the Scheme (the \"Effective Time\"), each outstanding Ordinary Share was converted into $116.50 in cash (the \"Consideration\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-052361","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123052361/doc4.xml","form_type":"4"}},{"id":1842074,"issuer":{"id":5739,"kind":"organization","name":"Century Therapeutics, Inc.","symbol":"IPSC"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-29T20:18:44.000Z","date":"2023-06-27","kind":"grant","planned":false,"acquired":true,"shares":44000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on the earlier of (a) June 27, 2024, or (b) the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":44000,"derivative":{"exercise_price":3.19,"expiration_date":"2024-06-27","underlying":"Common Stock","underlying_shares":44000},"source":{"system":"sec-edgar","filing":"0001062993-23-014165","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850119/000106299323014165/form4.xml","form_type":"4"}},{"id":1855973,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-14T22:00:19.000Z","date":"2023-06-12","kind":"grant","planned":false,"acquired":true,"shares":1417,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest on the first anniversary of the grant date, provided that the option will in any case be fully vested on the date of the Company's 2024 annual stockholder meeting."}],"balance_after":1417,"derivative":{"exercise_price":28.97,"expiration_date":"2033-06-11","underlying":"Common Stock","underlying_shares":1417},"source":{"system":"sec-edgar","filing":"0001209191-23-037135","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000120919123037135/doc4.xml","form_type":"4"}},{"id":1923823,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-04-06T23:04:15.000Z","date":"2023-04-05","kind":"grant","planned":false,"acquired":true,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest in equal annual installments over a three year period such that the option is fully vested on the third anniversary of the date of grant (April 5, 2023)."}],"balance_after":34000,"derivative":{"exercise_price":24.71,"expiration_date":"2033-04-04","underlying":"Common Stock","underlying_shares":34000},"source":{"system":"sec-edgar","filing":"0001209191-23-023648","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000120919123023648/doc4.xml","form_type":"4"}},{"id":2060361,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Performance Restricted Stock Units (PSUs)","published_at":"2023-01-06T17:48:19.000Z","date":"2023-01-05","kind":"exercise","acquired":false,"shares":39944,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each PSU/RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The remaining ordinary shares subject to the PSU/RSU vest on January 5, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The remaining ordinary shares subject to the PSU/RSU vest on January 5, 2024."}],"balance_after":17448,"derivative":{"underlying":"Ordinary Shares","underlying_shares":39944},"source":{"system":"sec-edgar","filing":"0001209191-23-002436","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123002436/doc4.xml","form_type":"4"}},{"id":2060360,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Performance Restricted Stock Units (PSUs)","published_at":"2023-01-06T17:48:19.000Z","date":"2023-01-05","kind":"exercise","acquired":false,"shares":23200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each PSU/RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The ordinary shares subject to the PSU vested on January 5, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"The ordinary shares subject to the PSU vested on January 5, 2023."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":23200},"source":{"system":"sec-edgar","filing":"0001209191-23-002436","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123002436/doc4.xml","form_type":"4"}},{"id":2060359,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Performance Restricted Stock Units (PSUs)","published_at":"2023-01-06T17:48:19.000Z","date":"2023-01-05","kind":"exercise","acquired":false,"shares":9435,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each PSU/RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The ordinary shares subject to the PSU vested on January 5, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"The ordinary shares subject to the PSU vested on January 5, 2023."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":9435},"source":{"system":"sec-edgar","filing":"0001209191-23-002436","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123002436/doc4.xml","form_type":"4"}},{"id":2060358,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Performance Restricted Stock Units (PSUs)","published_at":"2023-01-06T17:48:19.000Z","date":"2023-01-05","kind":"exercise","acquired":false,"shares":34835,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each PSU/RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The ordinary shares subject to the PSU vested on January 5, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"The ordinary shares subject to the PSU vested on January 5, 2023."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":34835},"source":{"system":"sec-edgar","filing":"0001209191-23-002436","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123002436/doc4.xml","form_type":"4"}},{"id":2060357,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Restricted Stock Units (RSUs)","published_at":"2023-01-06T17:48:19.000Z","date":"2023-01-05","kind":"exercise","acquired":false,"shares":24598,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each PSU/RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The remaining ordinary shares subject to the RSU vest ratably on January 5, 2024 and January 5, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The remaining ordinary shares subject to the RSU vest ratably on January 5, 2024 and January 5, 2025."}],"balance_after":49198,"derivative":{"underlying":"Ordinary Shares","underlying_shares":24598},"source":{"system":"sec-edgar","filing":"0001209191-23-002436","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123002436/doc4.xml","form_type":"4"}},{"id":2060356,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Restricted Stock Units (RSUs)","published_at":"2023-01-06T17:48:19.000Z","date":"2023-01-05","kind":"exercise","acquired":false,"shares":34928,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each PSU/RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The remaining ordinary shares subject to the PSU/RSU vest on January 5, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The remaining ordinary shares subject to the PSU/RSU vest on January 5, 2024."}],"balance_after":34929,"derivative":{"underlying":"Ordinary Shares","underlying_shares":34928},"source":{"system":"sec-edgar","filing":"0001209191-23-002436","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123002436/doc4.xml","form_type":"4"}},{"id":2060355,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Restricted Stock Units (RSUs)","published_at":"2023-01-06T17:48:19.000Z","date":"2023-01-05","kind":"exercise","acquired":false,"shares":58055,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each PSU/RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The final tranche of ordinary shares subject to the RSU vested on January 5, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The final tranche of ordinary shares subject to the RSU vested on January 5, 2023."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":58055},"source":{"system":"sec-edgar","filing":"0001209191-23-002436","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123002436/doc4.xml","form_type":"4"}},{"id":2060354,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Restricted Stock Units (RSUs)","published_at":"2023-01-06T17:48:19.000Z","date":"2023-01-04","kind":"grant","acquired":true,"shares":20697,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each PSU/RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vest 1/3rd annually on each anniversary of January 5, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vest 1/3rd annually on each anniversary of January 5, 2023."}],"balance_after":20697,"derivative":{"underlying":"Ordinary Shares","underlying_shares":20697},"source":{"system":"sec-edgar","filing":"0001209191-23-002436","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123002436/doc4.xml","form_type":"4"}},{"id":2060353,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Restricted Stock Units (RSUs)","published_at":"2023-01-06T17:48:19.000Z","date":"2023-01-04","kind":"grant","acquired":true,"shares":71290,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each PSU/RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vest 1/3rd annually on each anniversary of January 5, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vest 1/3rd annually on each anniversary of January 5, 2023."}],"balance_after":71290,"derivative":{"underlying":"Ordinary Shares","underlying_shares":71290},"source":{"system":"sec-edgar","filing":"0001209191-23-002436","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123002436/doc4.xml","form_type":"4"}},{"id":2060352,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Ordinary Shares","published_at":"2023-01-06T17:48:19.000Z","date":"2023-01-05","kind":"tax_withholding","acquired":false,"shares":97461,"price":113.24,"value":11036483.64,"ownership":{"direct":true},"balance_after":616493,"source":{"system":"sec-edgar","filing":"0001209191-23-002436","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123002436/doc4.xml","form_type":"4"}},{"id":2060351,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Ordinary Shares","published_at":"2023-01-06T17:48:19.000Z","date":"2023-01-05","kind":"exercise","acquired":true,"shares":219995,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each PSU/RSU represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":713954,"source":{"system":"sec-edgar","filing":"0001209191-23-002436","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123002436/doc4.xml","form_type":"4"}},{"id":2067394,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Performance Restricted Stock Units (PSUs)","published_at":"2023-01-04T16:21:41.000Z","date":"2023-01-01","kind":"exercise","acquired":false,"shares":104498,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each PSU/RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The ordinary shares subject to the PSU vested on January 1, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The ordinary shares subject to the PSU vested on January 1, 2023."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":104498},"source":{"system":"sec-edgar","filing":"0001209191-23-000918","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123000918/doc4.xml","form_type":"4"}},{"id":2067393,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Restricted Stock Units (RSUs)","published_at":"2023-01-04T16:21:41.000Z","date":"2022-12-30","kind":"exercise","acquired":false,"shares":7141,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each PSU/RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The remaining ordinary shares subject to the RSU vest ratably on January 5, 2024 and January 5, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The remaining ordinary shares subject to the RSU vest ratably on January 5, 2024 and January 5, 2025."}],"balance_after":14283,"derivative":{"underlying":"Ordinary Shares","underlying_shares":7141},"source":{"system":"sec-edgar","filing":"0001209191-23-000918","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123000918/doc4.xml","form_type":"4"}},{"id":2067392,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Restricted Stock Units (RSUs)","published_at":"2023-01-04T16:21:41.000Z","date":"2022-12-30","kind":"exercise","acquired":false,"shares":4657,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each PSU/RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The remaining ordinary shares subject to the RSU vest on January 5, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The remaining ordinary shares subject to the RSU vest on January 5, 2024."}],"balance_after":4657,"derivative":{"underlying":"Ordinary Shares","underlying_shares":4657},"source":{"system":"sec-edgar","filing":"0001209191-23-000918","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123000918/doc4.xml","form_type":"4"}},{"id":2067391,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Restricted Stock Units (RSUs)","published_at":"2023-01-04T16:21:41.000Z","date":"2022-12-30","kind":"exercise","acquired":false,"shares":3387,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each PSU/RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The final tranche of ordinary shares subject to the RSU vested on December 30, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The final tranche of ordinary shares subject to the RSU vested on December 30, 2022."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":3387},"source":{"system":"sec-edgar","filing":"0001209191-23-000918","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123000918/doc4.xml","form_type":"4"}},{"id":2067390,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Ordinary Shares","published_at":"2023-01-04T16:21:41.000Z","date":"2023-01-01","kind":"tax_withholding","acquired":false,"shares":46365,"price":113.8,"value":5276337.0,"ownership":{"direct":true},"balance_after":493959,"source":{"system":"sec-edgar","filing":"0001209191-23-000918","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123000918/doc4.xml","form_type":"4"}},{"id":2067389,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Ordinary Shares","published_at":"2023-01-04T16:21:41.000Z","date":"2023-01-01","kind":"exercise","acquired":true,"shares":104498,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each PSU/RSU represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":540324,"source":{"system":"sec-edgar","filing":"0001209191-23-000918","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123000918/doc4.xml","form_type":"4"}},{"id":2067388,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Ordinary Shares","published_at":"2023-01-04T16:21:41.000Z","date":"2022-12-30","kind":"tax_withholding","acquired":false,"shares":6729,"price":113.8,"value":765760.2,"ownership":{"direct":false,"nature":"By Spouse"},"balance_after":49656,"source":{"system":"sec-edgar","filing":"0001209191-23-000918","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123000918/doc4.xml","form_type":"4"}},{"id":2067387,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Ordinary Shares","published_at":"2023-01-04T16:21:41.000Z","date":"2022-12-30","kind":"exercise","acquired":true,"shares":15185,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each PSU/RSU represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":56385,"source":{"system":"sec-edgar","filing":"0001209191-23-000918","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919123000918/doc4.xml","form_type":"4"}},{"id":2074940,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Performance Restricted Stock Units (PSUs)","published_at":"2022-12-29T16:33:20.000Z","date":"2022-12-27","kind":"grant","acquired":true,"shares":52392,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each PSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F3","text":"On January 4, 2021, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On December 27, 2022, such performance criteria were met. Two-thirds of the ordinary shares subject to the PSUs vest on January 5, 2023 and the remaining one-third of the ordinary shares vest on January 5, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On January 4, 2021, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On December 27, 2022, such performance criteria were met. Two-thirds of the ordinary shares subject to the PSUs vest on January 5, 2023 and the remaining one-third of the ordinary shares vest on January 5, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On January 4, 2021, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On December 27, 2022, such performance criteria were met. Two-thirds of the ordinary shares subject to the PSUs vest on January 5, 2023 and the remaining one-third of the ordinary shares vest on January 5, 2024."}],"balance_after":52392,"derivative":{"underlying":"Ordinary Shares","underlying_shares":52392},"source":{"system":"sec-edgar","filing":"0001209191-22-062918","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919122062918/doc4.xml","form_type":"4"}},{"id":2074939,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Performance Restricted Stock Units (PSUs)","published_at":"2022-12-29T16:33:20.000Z","date":"2022-12-27","kind":"grant","acquired":true,"shares":104498,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each PSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On January 3, 2020, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On December 27, 2022, such performance criteria were me.   The ordinary shares subject to the PSUs vest on January 1, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On January 3, 2020, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On December 27, 2022, such performance criteria were me.   The ordinary shares subject to the PSUs vest on January 1, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On January 3, 2020, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On December 27, 2022, such performance criteria were me.   The ordinary shares subject to the PSUs vest on January 1, 2023."}],"balance_after":104498,"derivative":{"underlying":"Ordinary Shares","underlying_shares":104498},"source":{"system":"sec-edgar","filing":"0001209191-22-062918","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919122062918/doc4.xml","form_type":"4"}},{"id":2147575,"issuer":{"id":5739,"kind":"organization","name":"Century Therapeutics, Inc.","symbol":"IPSC"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-10-03T20:07:00.000Z","date":"2022-10-01","kind":"grant","acquired":true,"shares":39744,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Century Therapeutics, Inc. (the \"Company\") issued Mr. Walbert stock options (the \"Options\") in connection with his appointment as a director. The Options vest in equal monthly installments over 36 months subject to Mr. Walbert's continued service to the Company and are issued pursuant to the Company's 2021 Equity Incentive Plan."}],"balance_after":39744,"derivative":{"exercise_price":9.89,"expiration_date":"2032-10-01","underlying":"Common Stock","underlying_shares":39744},"source":{"system":"sec-edgar","filing":"0001062993-22-020143","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850119/000106299322020143/form4.xml","form_type":"4"}},{"id":2244611,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-03T19:04:12.000Z","date":"2022-06-03","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The stock option is fully vested and exercisable."}],"balance_after":742565,"derivative":{"exercise_price":22.14,"expiration_date":"2025-03-22","underlying":"Ordinary Shares","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-22-034349","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919122034349/doc4.xml","form_type":"4"}},{"id":2244610,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Ordinary Shares","published_at":"2022-06-03T19:04:12.000Z","date":"2022-06-03","kind":"sale","acquired":false,"shares":9800,"price":92.74,"value":908852.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 1, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.47 to $93.27 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":435826,"source":{"system":"sec-edgar","filing":"0001209191-22-034349","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919122034349/doc4.xml","form_type":"4"}},{"id":2244609,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Ordinary Shares","published_at":"2022-06-03T19:04:12.000Z","date":"2022-06-03","kind":"sale","acquired":false,"shares":15200,"price":92.08,"value":1399616.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 1, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.46 to $92.45 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":445626,"source":{"system":"sec-edgar","filing":"0001209191-22-034349","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919122034349/doc4.xml","form_type":"4"}},{"id":2244608,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Ordinary Shares","published_at":"2022-06-03T19:04:12.000Z","date":"2022-06-03","kind":"exercise","acquired":true,"shares":25000,"price":22.14,"value":553500.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 277 ordinary shares of the Issuer acquired by the reporting person on June 1, 2022 pursuant to an employee stock purchase program."}],"balance_after":460826,"source":{"system":"sec-edgar","filing":"0001209191-22-034349","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919122034349/doc4.xml","form_type":"4"}},{"id":2247456,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Ordinary Shares","published_at":"2022-06-02T16:13:55.000Z","date":"2022-05-31","kind":"sale","acquired":false,"shares":2700,"price":94.46,"value":255042.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 1, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.88 to $94.96 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":435549,"source":{"system":"sec-edgar","filing":"0001209191-22-033505","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919122033505/doc4.xml","form_type":"4"}},{"id":2247455,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Ordinary Shares","published_at":"2022-06-02T16:13:55.000Z","date":"2022-05-31","kind":"sale","acquired":false,"shares":3800,"price":93.21,"value":354198.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 1, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.85 to $93.69 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":438249,"source":{"system":"sec-edgar","filing":"0001209191-22-033505","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919122033505/doc4.xml","form_type":"4"}},{"id":2247454,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Ordinary Shares","published_at":"2022-06-02T16:13:55.000Z","date":"2022-05-31","kind":"sale","acquired":false,"shares":18500,"price":92.04,"value":1702740.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 1, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.72 to $92.54 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":442049,"source":{"system":"sec-edgar","filing":"0001209191-22-033505","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919122033505/doc4.xml","form_type":"4"}},{"id":2261503,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-20T20:09:09.000Z","date":"2022-05-18","kind":"grant","acquired":true,"shares":14612,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in twelve equal monthly installments commencing on June 18, 2022."}],"balance_after":14612,"derivative":{"exercise_price":11.45,"expiration_date":"2032-05-18","underlying":"Common Stock","underlying_shares":14612},"source":{"system":"sec-edgar","filing":"0001628280-22-015032","document":"wf-form4_165307732544689.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1349376/000162828022015032/wf-form4_165307732544689.xml","form_type":"4"}},{"id":2261502,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2022-05-20T20:09:09.000Z","date":"2022-05-18","kind":"grant","acquired":true,"shares":8733,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuers common stock. The RSUs will vest and be delivered to the Reporting Person one year from date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuers common stock. The RSUs will vest and be delivered to the Reporting Person one year from date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuers common stock. The RSUs will vest and be delivered to the Reporting Person one year from date of grant."}],"balance_after":8733,"derivative":{"underlying":"Common Shares","underlying_shares":8733},"source":{"system":"sec-edgar","filing":"0001628280-22-015032","document":"wf-form4_165307732544689.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1349376/000162828022015032/wf-form4_165307732544689.xml","form_type":"4"}},{"id":2261794,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-20T18:15:04.000Z","date":"2022-05-20","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option is fully vested and exercisable."}],"balance_after":767565,"derivative":{"exercise_price":22.14,"expiration_date":"2025-03-22","underlying":"Ordinary Shares","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-22-031126","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919122031126/doc4.xml","form_type":"4"}},{"id":2261793,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Ordinary Shares","published_at":"2022-05-20T18:15:04.000Z","date":"2022-05-20","kind":"sale","acquired":false,"shares":25000,"price":90,"value":2250000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 1, 2021."}],"balance_after":460549,"source":{"system":"sec-edgar","filing":"0001209191-22-031126","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919122031126/doc4.xml","form_type":"4"}},{"id":2261792,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Ordinary Shares","published_at":"2022-05-20T18:15:04.000Z","date":"2022-05-20","kind":"exercise","acquired":true,"shares":25000,"price":22.14,"value":553500.0,"ownership":{"direct":true},"balance_after":485549,"source":{"system":"sec-edgar","filing":"0001209191-22-031126","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919122031126/doc4.xml","form_type":"4"}},{"id":2271995,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-13T16:31:24.000Z","date":"2022-05-11","kind":"exercise","acquired":false,"shares":17600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option is fully vested and exercisable."}],"balance_after":792565,"derivative":{"exercise_price":22.14,"expiration_date":"2025-03-22","underlying":"Ordinary Shares","underlying_shares":17600},"source":{"system":"sec-edgar","filing":"0001209191-22-028884","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919122028884/doc4.xml","form_type":"4"}},{"id":2271994,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Ordinary Shares","published_at":"2022-05-13T16:31:24.000Z","date":"2022-05-11","kind":"sale","acquired":false,"shares":17600,"price":90,"value":1584000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 1, 2021."}],"balance_after":460549,"source":{"system":"sec-edgar","filing":"0001209191-22-028884","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919122028884/doc4.xml","form_type":"4"}},{"id":2271993,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Ordinary Shares","published_at":"2022-05-13T16:31:24.000Z","date":"2022-05-11","kind":"exercise","acquired":true,"shares":17600,"price":22.14,"value":389664.0,"ownership":{"direct":true},"balance_after":478149,"source":{"system":"sec-edgar","filing":"0001209191-22-028884","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919122028884/doc4.xml","form_type":"4"}},{"id":2276137,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-10T17:59:31.000Z","date":"2022-05-06","kind":"exercise","acquired":false,"shares":7400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option is fully vested and exercisable."}],"balance_after":810165,"derivative":{"exercise_price":22.14,"expiration_date":"2025-03-22","underlying":"Ordinary Shares","underlying_shares":7400},"source":{"system":"sec-edgar","filing":"0001209191-22-028129","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919122028129/doc4.xml","form_type":"4"}},{"id":2276136,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Ordinary Shares","published_at":"2022-05-10T17:59:31.000Z","date":"2022-05-06","kind":"sale","acquired":false,"shares":5000,"price":91.11,"value":455550.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 1, 2021."}],"balance_after":460549,"source":{"system":"sec-edgar","filing":"0001209191-22-028129","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919122028129/doc4.xml","form_type":"4"}},{"id":2276135,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Ordinary Shares","published_at":"2022-05-10T17:59:31.000Z","date":"2022-05-06","kind":"sale","acquired":false,"shares":2400,"price":90.33,"value":216792.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 1, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.00 to $90.9 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":465549,"source":{"system":"sec-edgar","filing":"0001209191-22-028129","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919122028129/doc4.xml","form_type":"4"}},{"id":2276134,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Ordinary Shares","published_at":"2022-05-10T17:59:31.000Z","date":"2022-05-06","kind":"exercise","acquired":true,"shares":7400,"price":22.14,"value":163836.0,"ownership":{"direct":true},"balance_after":467949,"source":{"system":"sec-edgar","filing":"0001209191-22-028129","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919122028129/doc4.xml","form_type":"4"}},{"id":2282284,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Ordinary Shares","published_at":"2022-05-04T16:24:17.000Z","date":"2022-05-02","kind":"sale","acquired":false,"shares":3450,"price":97.43,"value":336133.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 1, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.13 to $97.93 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":460549,"source":{"system":"sec-edgar","filing":"0001209191-22-027083","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919122027083/doc4.xml","form_type":"4"}},{"id":2282283,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Ordinary Shares","published_at":"2022-05-04T16:24:17.000Z","date":"2022-05-02","kind":"sale","acquired":false,"shares":7608,"price":96.62,"value":735084.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 1, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.07 to $97.07 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":463999,"source":{"system":"sec-edgar","filing":"0001209191-22-027083","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919122027083/doc4.xml","form_type":"4"}},{"id":2282282,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Ordinary Shares","published_at":"2022-05-04T16:24:17.000Z","date":"2022-05-02","kind":"sale","acquired":false,"shares":13942,"price":95.38,"value":1329787.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 1, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.05 to $96.005 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":471607,"source":{"system":"sec-edgar","filing":"0001209191-22-027083","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919122027083/doc4.xml","form_type":"4"}},{"id":2291788,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-22T18:49:38.000Z","date":"2022-04-22","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The stock option is fully vested and exercisable."}],"balance_after":817565,"derivative":{"exercise_price":22.14,"expiration_date":"2025-03-22","underlying":"Ordinary Shares","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-22-025457","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919122025457/doc4.xml","form_type":"4"}},{"id":2291787,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Ordinary Shares","published_at":"2022-04-22T18:49:38.000Z","date":"2022-04-22","kind":"sale","acquired":false,"shares":1087,"price":109.39,"value":118906.93,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 1, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.82 to $109.89 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":485549,"source":{"system":"sec-edgar","filing":"0001209191-22-025457","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919122025457/doc4.xml","form_type":"4"}},{"id":2291786,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Ordinary Shares","published_at":"2022-04-22T18:49:38.000Z","date":"2022-04-22","kind":"sale","acquired":false,"shares":1800,"price":107.94,"value":194292.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 1, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.66 to $108.49 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":486636,"source":{"system":"sec-edgar","filing":"0001209191-22-025457","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919122025457/doc4.xml","form_type":"4"}},{"id":2291785,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Ordinary Shares","published_at":"2022-04-22T18:49:38.000Z","date":"2022-04-22","kind":"sale","acquired":false,"shares":5700,"price":107.02,"value":610014.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 1, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.57 to $107.565 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":488436,"source":{"system":"sec-edgar","filing":"0001209191-22-025457","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919122025457/doc4.xml","form_type":"4"}},{"id":2291784,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":25937,"kind":"person","name":"Walbert Timothy P","position":1,"cik":"0001349376","reported_name":"Walbert Timothy P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Ordinary Shares","published_at":"2022-04-22T18:49:38.000Z","date":"2022-04-22","kind":"sale","acquired":false,"shares":16413,"price":106.1,"value":1741419.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 1, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.56 to $106.56 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":494136,"source":{"system":"sec-edgar","filing":"0001209191-22-025457","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919122025457/doc4.xml","form_type":"4"}}],"next_cursor":"2022-04-22T18:49:38.000000Z,2291784"}